FY 2024 ~
-
Dementia-treatment study based on cellular and molecular mechanisms of protective variantsHaruhisa InoueProfessor, Center for iPS Cell Research and Application (CiRA), Kyoto University
-
Discovery of brain circuit biomarkers and development of neurofeedback therapy based on generative/adversarial AI and digital brainsAurelio CorteseHead, Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International
-
Unleashing a New Era: Pioneering Therapies for α-SynucleinopathiesNobutaka HattoriProfessor and Chairperson, Juntendo University Faculty of Medicine
-
Multi-layer sequencing of germline, somatic, virus variants accelerate seeds development of autoimmune neurological diseasesYukinori OkadaProfessor, The University of Tokyo Graduate School of Medicine
-
Development of a comprehensive blood biomarker system capable of assessing the background pathology of dementia using PET as a reference standardKenji TagaiResearcher, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST)
-
Development of Therapeutic Seeds Based on Functional Analysis of Alzheimer’s Disease Causative GenesHideaki MatsuiProfessor, Brain Research Institute, Niigata University
-
Proof of concept study of data-driven novel therapeutic agents for obsessive-compulsive disorder and their indication expansionNozomi AsaokaAssistant professor, Kyoto University Graduate School of Medicine
-
Analysis of plasma components involved in the development of dementia and development of transplantation therapyNariko ArimuraAssociate Professor, Tohoku University Graduate School of Pharmaceutical Science
-
Development of a novel therapy for tauopathy: a MARK4 inhibitorKanae AndoAssociate Professor, Tokyo Metropolitan University School of Science
-
Study of Immune Cells in Autism Spectrum DisordersMinako ItoAssociate Professor, Medical Institute of Bioregulation, Kyushu University
-
Development of Novel Brain Disease Therapy Based on the Bioprotective Effects of Senescent MicrogliaHiroshi OhnishiProfessor, Gunma University Graduate School of Health Sciences
-
Exploratory research on suppression of amyloid β aggregation by Auger electronsMasahiro OnoProfessor, Kyoto University Graduate School of Pharmaceutical Sciences
-
Development of antisense oligonucleotides that enable highly efficient RNA editing at pathogenic point mutationsYukio KawaharaProfessor, Osaka University Graduate School of Medicine
-
Therapeutic Strategy on neurodegenerative pathology by microglial regulationKimitoshi KimuraProgram-Specific Junior Associate Professor, Kyoto University Graduate School of Medicine
-
The Potential of Olfaction in an Aging Society: Establishing Methods for Predicting and Preventing Dementia Through ScentHaruki TakeuchiProfessor, The University of Tokyo Graduate School of Science
-
Study on the role of progressive complex ubiquitination in neurodegenerative diseases-associated inclusions and the disease-suppressing effects of ubiquitin ligase inhibitorsFuminori TokunagaProfessor, Osaka Metropolitan University Graduate School of Medicine
-
Study of EEG-NF to treat phantom limb painTakufumi YanagisawaProfessor, Osaka University Graduate School of medicine
FY 2025 ~
-
Development of diagnostic and therapeutic methods based on high-risk variants of autistic spectrum disorders using IGF-1 receptor agonists as a starting pointNorio OzakiDesignated Professor, Nagoya University Graduate School of Medicine
-
Identification of targets for therapeutic intervention in sporadic amyotrophic lateral sclerosis and development of drug seeds: through integrated analysis of large-scale clinical genomic information and patient-derived iPS cells/motor neuronsGen SobuePresident, Aichi Medical University
-
Innovative Early Diagnostic Development Using Integrated αSynuclein-PET/Longitudinal MRI and Acceleration of Disease-Modifying Therapy via Molecular Pathology-Based Trial-Ready Cohort in Multiple System AtrophyHironobu EndoSenior Researcher, Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology
-
Identification of extreme cases by stratification of psychiatric disorders and research on drug discovery seeds using highly validated animal and cellular models based on extreme casesRyota HashimotoDirector, National Institute of Mental Health, National Center of Neurology and Psychiatry
-
Development of an ALS/FTLD Therapy Using a Long-Acting Nucleic Acid Drug That Targets TDP-43 Phase SeparationShinsuke IshigakiProfessor, Molecular Neuroscience Research Center, Shiga University of Medical Science
-
Elucidation of the aging mechanism of fibroblasts in cerebrovascular diseases and its therapeutic applicationTakakuni MakiLecturer, Kyoto University Graduate School of Medicine
-
Development of a Novel Device for Evaluating Myelin Repair and Its Application for Drug DiscoveryRieko MuramatsuDirector, National Institute of Neuroscience, National Center of Neurology and Psychiatry